Large Kellogg Eye Center study shows cases of herpes zoster ophthalmicus tripled in 12 year time span, highest among older adults

A new grant will allow Michigan Medicine researchers to explore personalized approaches to treating autoimmune diseases such as scleroderma, lupus, rheumatoid arthritis and others.

A U-M study is the first to define how a little-known type of cell death impacts tumor cells and immune cells.

Researchers cause a lupus-like disease in mice by amplifying the amount of a single “master regulator” factor — suggesting both a root cause for known differences between the sexes and a target for new treatments.

Michigan Medicine researchers identify a potential therapeutic target for neurodegenerative conditions using animal models.

A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.

A Kellogg Eye Center study finds great promise in corneal transplants for patients who suffer shingles and develop subsequent vision-limiting corneal scarring.

A tool borrowed from bacteria successfully seeks out, cuts and destroys long stretches of human cells’ DNA, opening doors to new uses in research and treatment.

An enzyme’s newly discovered ability to spur the body to prevent or repair acute liver injury could be harnessed as a therapy or used as a biomarker.

Inhibition of atypical kinase C may help manage macular edema and vision loss associated with eye diseases

A pilot study identifies a safe, effective strategy to help women with HIV have children in low-resource countries.

New research finds that parents and children talk and interact less with electronic books compared to print books.

Researchers have shown how tumor-associated macrophages release compounds that block gemcitabine in the most common type of pancreatic cancer

While it plays a protective role in other diseases, knocking out NLRP6 in mice led to better outcomes, less-severe symptoms after bone marrow transplant.

A new paper identifies strategies that providers might use to help their patients better balance the risks and benefits of anticoagulants.